Table: Peptidream - 9-MTH parent results
May 12 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Mar 31, 2017 Mar 31, 2016 Jun 30, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.42 2.68
(-47.1 pct) (+400.7 pct)
Operating 107 mln 1.54
(-93.0 pct)
Recurring 235 mln 1.46
(-83.5 pct)
Net 164 mln 977 mln
(-83.2 pct)
EPS 2.88 yen 17.65 yen
EPS Diluted 2.53 yen 15.18 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner